Postinfarction ventricular septal defect closure

2021 ◽  
Keyword(s):  
Ventricular Septal Defect ◽  
Septal Defect ◽  
Suture Line ◽  
Left Ventricular ◽  
Ventricular Wall ◽  
Defect Closure ◽  
Usual Manner ◽  
Ventricular Septal Defect Closure ◽  
Postinfarction Ventricular Septal Defect ◽  
The Right

After a median full sternotomy, cardiopulmonary bypass is installed in the usual manner. Apical ventriculotomy is performed through the infarcted myocardium. Polypropylene pledgeted mattress sutures are passed from the right to the left ventricular side through the ventricular septal defect, with the pledgets remaining on the right ventricle. Great care must be taken to place the suture on healthy myocardium and away from the edge of the ventricular septal defect; otherwise the chances of a recurrent postoperative ventricular septal defect would increase. The sutures are subsequently positioned through a heterologous patch, previously prepared to be appropriate for the ventricular septal defect closure. A collar of 3 to 4 cm is left on the external side of the patch. A 4-0 polypropylene running suture is placed through this collar and the left ventricle to further reinforce the ventricular septal defect closure. The left ventricular incision is closed with polypropylene 3-0 continuous sutures. For each ventricular edge, the running suture is passed through 2 polytetrafluoroethylene felts: one on the endoventricular side and the other on the epicardial side. Finally, the suture line is reinforced with a continuous 2-0 polypropylene suture, which is passed through the polytetrafluoroethylene felts, the ventricular wall, and the heterologous patch used to close the ventricular septal defect.

scholarly journals Direct Percutaneous Repair of Left Ventricular Pseudoaneurysm via Transthoracic Deployment of a Ventricular Septal Defect Closure Device

2015 ◽  
Vol 42 (4) ◽  
pp. 362-366 ◽  
Author(s):  
John Moriarty ◽  
Tyler J. Harris ◽  
Gabriel Vorobiof ◽  
Murray Kwon ◽  
Jamil Aboulhosn
Keyword(s):  
Case Report ◽  
Ventricular Septal Defect ◽  
Septal Defect ◽  
Left Ventricular ◽  
Closure Device ◽  
Defect Closure ◽  
Left Ventricular Pseudoaneurysm ◽  
Muscular Ventricular Septal Defect ◽  
Ventricular Septal Defect Closure ◽  
Occluder Device

In this case report, we describe direct percutaneous delivery of a muscular-ventricular-septal-defect occluder device to close a left ventricular pseudoaneurysm. The occluder was positioned and deployed with the aid of concurrent transthoracic ultrasonography, transesophageal echocardiography, and fluoroscopy. In contrast with previously published reports, we describe and illustrate a direct transthoracic route across the pseudoaneurysmal sac, which obviated the need for indirect transfemoral or transapical approaches.

Percutaneous closure of ventricular septal defect using LifeTechTM Konar-MF VSD Occluder: initial and short-term multi-institutional results

2021 ◽  
pp. 1-7
Author(s):  
Masood Sadiq ◽  
Ahmad Usaid Qureshi ◽  
Muhammad Younas ◽  
Sohail Arshad ◽  
Syed Najam Hyder
Keyword(s):  
Ventricular Septal Defect ◽  
Aortic Regurgitation ◽  
Septal Defect ◽  
Defect Closure ◽  
Short Term ◽  
Ventricular Septal Defect Closure ◽  
Coronary Cusp ◽  
The Right ◽  
Right Coronary Cusp

Abstract Background: Transcatheter ventricular septal defect closure remains a complex procedure with potential complications like complete heart block and aortic regurgitation. The ideal device design for such intervention is still evolving. Aim: To assess the safety, efficacy, and short-term outcome of ventricular septal defect closure using LifeTechTM multifunctional (KONAR-MFTM) VSD Occluder. Patients and methods: In a multicenre study, 44 patients with haemodynamically significant, restrictive ventricular septal defects underwent closure with the KONAR-MFTM device from April, 2019 to March, 2020. Clinical, echocardiographic, and angiographic data were collected and reviewed. Patients were followed up at 1, 3, 6, and 12 months. Results: The median age and weight were 8 (1.7–36) years and 20 (11–79) kg. Of 44 patients, 8 (18%) had a high muscular and 36 (82%) had a perimembranous defect, of which 6 had mild prolapse of the right coronary cusp. The median ventricular septal defect size was 8.8 (3.9–13.4) mm. A retrograde approach was adopted in 39 (88.6%) patients. Nine patients (20.5%) had a small residual leak and there was a slight increase in aortic regurgitation in one patient. One device, which embolised to pulmonary artery was retrieved, and the defect was closed with a larger device. At a median follow-up of 13 (5–18) months, the residual leak persisted in 1 (2.3%) patient. Mild aortic regurgitation in one patient remained unchanged. There were no major complications. Conclusion: Percutaneous closure of ventricular septal defect using KONAR-MFTM device is safe and effective in short and midterm follow-up including selected patients with perimembranous defect and mild prolapse of the right coronary cusp.

Percutaneous closure of a left ventricular pseudoaneurysm after transcatheter ventricular septal defect closure

2020 ◽  
Vol 30 (5) ◽  
pp. 743-745
Author(s):  
Selman Gokalp ◽  
Sezen Ugan Atik ◽  
Irfan L. Saltik
Keyword(s):  
Ventricular Septal Defect ◽  
Conventional Treatment ◽  
Septal Defect ◽  
Left Ventricular ◽  
Percutaneous Closure ◽  
Defect Closure ◽  
Device Closure ◽  
Left Ventricular Pseudoaneurysm ◽  
First Case ◽  
Ventricular Septal Defect Closure

AbstractLeft ventricular pseudoaneurysm is very rare in children. Although surgery is conventional treatment, recently, percutaneous closure of pseudoaneurysms has been described. Here, we present the first case where a patient developed left ventricular pseudoaneurysm after percutaneous ventricular septal defect device closure and was treated by a second percutaneous method.

Echogenic mass in the right atrium after surgical ventricular septal defect closure: thrombus or tumour?

2010 ◽  
Vol 20 (1) ◽  
pp. 86-88 ◽  
Author(s):  
Nicole de Winkel ◽  
Karen Becker ◽  
Manfred Vogt
Keyword(s):  
Ventricular Septal Defect ◽  
Right Atrium ◽  
Septal Defect ◽  
Histopathological Examination ◽  
Defect Closure ◽  
Unfractioned Heparin ◽  
Septal Defects ◽  
Atrial Septal Defects ◽  
Ventricular Septal Defect Closure ◽  
The Right

AbstractWe describe a neonate who presented with an echogenic mass in the right atrium 8 weeks after closure of ventricular and atrial septal defects. On a routine post operative check up after discharge, a mass was detected in the right atrium on echocardiography. As a thrombotic formation was suggested, lysis was started, in combination with the administration of unfractioned heparin. As there was no change in echogenicity or size of the mass, it was surgically excised. Histopathological examination revealed a myofibroblastic inflammatory tumour.

Sign in / Sign up

Export Citation Format

Share Document